Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

This study has been completed.

Study NCT00489931 Information provided by National Institutes of Health Clinical Center (CC)

First Received: June 20, 2007 Last Updated: April 16, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	No date given